BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2867562)

  • 21. Kappa opioid receptors stimulate phosphoinositide turnover in rat brain.
    Periyasamy S; Hoss W
    Life Sci; 1990; 47(3):219-25. PubMed ID: 1975082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.
    Dykstra LA; Gmerek DE; Winger G; Woods JH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):421-7. PubMed ID: 3302207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased immunoreactive dynorphin and leu-enkephalin in posterior pituitary of obese mice (ob/ob) and super-sensitivity to drugs that act at kappa receptors.
    Ferguson-Segall M; Flynn JJ; Walker J; Margules DL
    Life Sci; 1982 Nov 15-22; 31(20-21):2233-6. PubMed ID: 6131356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid receptor agonists in the rabbit colon: comparison of in vivo and in vitro studies.
    Pairet M; Ruckebusch Y
    Life Sci; 1984 Oct; 35(16):1653-8. PubMed ID: 6148681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
    Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
    Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
    Knox RJ; Dickenson AH
    Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of kappa-opioid receptor agonists and morphine on food intake and urinary output in food-deprived and nondeprived rats.
    Ramarao P; Bhargava HN
    Pharmacol Biochem Behav; 1989 Jun; 33(2):375-80. PubMed ID: 2554341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A kappa opioid effect: increased urination in the rat.
    Leander JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
    Bhargava HN; Ramarao P; Gulati A
    Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
    Das S; Bhargava HN
    Neuropharmacology; 1987 Aug; 26(8):1141-6. PubMed ID: 2889163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs.
    Gué M; Junien JL; Bueno L
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1006-10. PubMed ID: 2550612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TENA, a selective kappa opioid receptor antagonist.
    Portoghese PS; Takemori AE
    Life Sci; 1985 Feb; 36(8):801-5. PubMed ID: 2983171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration.
    Gmerek DE; Dykstra LA; Woods JH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):428-36. PubMed ID: 3302208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of U50,488, a selective kappa agonist, on atypical mouse opiate systems.
    Marrazzi MA; Lawhorn J; Graham V; L'Abbe D; Mullings-Britton J; Stack L; Eccles T
    Brain Res Bull; 1990 Jul; 25(1):199-201. PubMed ID: 2169965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL; Nayanar V; Walker JS
    Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orally administered kappa but not mu opiate agonists enhance gastric emptying of a solid canned food meal in dogs.
    Gué M; Fioramonti J; Junien JL; Bueno L
    J Pharm Pharmacol; 1988 Dec; 40(12):873-5. PubMed ID: 2907581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
    Ho BY; Takemori AE
    J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kappa opioid receptor, ingestive behaviors and the obese mouse (ob/ob).
    Morley JE; Levine AS; Gosnell BA; Kneip J; Grace M
    Physiol Behav; 1983 Nov; 31(5):603-6. PubMed ID: 6320237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of kappa opioid receptors in the rabbit ear artery.
    Berzetei IP; Fong A; Yamamura HI; Duckles SP
    Eur J Pharmacol; 1988 Jul; 151(3):449-55. PubMed ID: 2905660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.